Paper11029552
Ribozyme uses in retinal gene therapy.
Hauswirth WW and 1 other. Prog Retin Eye Res, 2000. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Ribozyme uses in retinal gene therapy. Papers, record 11029552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11029552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Therapy | Major topic |
| RNA, Catalytic | Major topic |
| Retinal Diseases | Major topic |
| Animals | |
| Genes, Dominant | |
| Genetic Vectors | |
| Humans | |
| Protein Structure, Secondary | |
| Retinitis Pigmentosa |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34768969 | The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34768969 | PubMed |
| 34722588 | Gene Therapy in Inherited Retinal Diseases: An Update on Current State of the Art. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34722588 | PubMed |
| 32120883 | Metabolic and Redox Signaling of the Nucleoredoxin-Like-1 Gene for the Treatment of Genetic Retinal Diseases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32120883 | PubMed |
| 29326851 | Recent Advancements in Gene Therapy for Hereditary Retinal Dystrophies. | Turk J Ophthalmol | 2017 | https://conductscience.org/library/papers/29326851 | PubMed |
| 27233447 | A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets. | Exp Eye Res | 2016 | https://conductscience.org/library/papers/27233447 | PubMed |
| 24391438 | Advances in gene therapy technologies to treat retinitis pigmentosa. | Clin Ophthalmol | 2014 | https://conductscience.org/library/papers/24391438 | PubMed |
| 23077406 | Gene therapy in animal models of autosomal dominant retinitis pigmentosa. | Mol Vis | 2012 | https://conductscience.org/library/papers/23077406 | PubMed |
| 22089493 | Gene-based therapies for dominantly inherited retinopathies. | Gene Ther | 2012 | https://conductscience.org/library/papers/22089493 | PubMed |
| 21785698 | Variables and strategies in development of therapeutic post-transcriptional gene silencing agents. | J Ophthalmol | 2011 | https://conductscience.org/library/papers/21785698 | PubMed |
| 20238065 | Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa. | Adv Exp Med Biol | 2010 | https://conductscience.org/library/papers/20238065 | PubMed |
| 19387072 | The effects of transient retinal detachment on cavity size and glial and neural remodeling in a mouse model of X-linked retinoschisis. | Invest Ophthalmol Vis Sci | 2009 | https://conductscience.org/library/papers/19387072 | PubMed |
| 19174761 | Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy. | Mol Ther | 2009 | https://conductscience.org/library/papers/19174761 | PubMed |
| 17564969 | RNA interference-mediated suppression and replacement of human rhodopsin in vivo. | Am J Hum Genet | 2007 | https://conductscience.org/library/papers/17564969 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11029552
GET https://conductscience.org/api/papers/v1/11029552/authors